This chemical is primarily used in pharmaceutical research and development, particularly in the synthesis of peptide-based drugs. It serves as a key intermediate in the production of compounds targeting specific biological pathways. Its structure, featuring a tert-butoxycarbonyl (Boc) protecting group and a methylsulfonamido moiety, makes it valuable for designing molecules with enhanced stability and bioavailability. It is often employed in the creation of inhibitors or modulators for enzymes or receptors, especially in the context of inflammation, cancer, or metabolic disorders. Additionally, its chiral center allows for the development of enantiomerically pure drugs, which is crucial for optimizing therapeutic efficacy and reducing side effects.